Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Chlorpheniramine Maleate Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering.
The global chlorpheniramine maleate market is expected to reach an estimated $605.9 billion by 2030 with a CAGR of 4.6% from 2024 to 2030. The major drivers for this market are an increase in the frequency of allergies and associated respiratory diseases such hives and allergic rhinitis, increase in pharmaceutical companies' R&D expenditures to create more potent antihistaminic medications, as well as, developments in medication delivery technologies and pharmaceuticals.
The future of the market looks promising with opportunities in the hospital pharmacy retail pharmacy, and online pharmacy markets. This study includes a forecast for the global chlorpheniramine maleate by dosage form, application, distribution channel, and region.
Chlorpheniramine Maleate Market by Dosage Form [Shipment Analysis by Value from 2018 to 2030]:
- Tablets
- Syrup
- Eye Drops
Chlorpheniramine Maleate Market by Application [Shipment Analysis by Value from 2018 to 2030]:
- Allergy
- Hay Fever (Allergic Rhinitis)
- Common Cold
- Watery Eyes
- Itchy Throat/Skin
- Anaphylactic Shock
- Urticaria
Chlorpheniramine Maleate Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Chlorpheniramine Maleate Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Chlorpheniramine Maleate Market Insights
- Tablets will remain the larger segment over the forecast period due to rise in prevalence of allergy and the easy availability of chlorpheniramine maleate tablets.
- APAC is expected to witness highest growth over the forecast period due to increasing prevalence of allergic diseases, increasing the number of leading market players who produce chlorpheniramine maleate and raising consumer awareness about allergies.
List of Chlorpheniramine Maleate Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chlorpheniramine maleate companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chlorpheniramine maleate companies profiled in this report include:
- Johnson & Johnson
- GlaxoSmithKline
- Merck & Co
- Zydus Lifesciences
- Sun Pharmaceutical Industries
- Viatris
- Alkem Laboratories
Features of the Global Chlorpheniramine Maleate Market
- Market Size Estimates: Chlorpheniramine maleate market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Chlorpheniramine maleate market size by dosage form, application, distribution channel, and region in terms of value ($B).
- Regional Analysis: Chlorpheniramine maleate market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different dosage form, application, distribution channel, and regions for the chlorpheniramine maleate market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chlorpheniramine maleate market.
- Analysis of competitive intensity of the industry based on Porter's Five Forces model.
For more information about this report visit https://www.researchandmarkets.com/r/i9t0vy
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
